ArticleBiomedicines2022

Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data.

Leanne Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.